Epithelial Ovarian Carcinoma clinical trials

Explore recruiting epithelial ovarian carcinoma clinical trials.

Recruiting epithelial ovarian carcinoma studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Epithelial Ovarian Carcinoma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Letrozole for Estrogen/Progesterone Receptor positive low-grade serous Epithelial ovarian cancer. A randomized phase III trial. LEPRE Trial

Italy, Czechia

Therapeutic confirmatory (Phase III) EU CTIS Study details

EPITOME-1015-I: A phase I study to investigate the safety and tolerability of MDG1015 in patients with epithelial ovarian cancer, gastroesophageal adenocarcinoma, round cell liposarcoma and/or synovial sarcoma

Netherlands

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

Epithelial Ovarian Carcinoma trials by city

Epithelial Ovarian Carcinoma clinical trials

Recruiting epithelial ovarian carcinoma studies right now

A Study of ILB2109 and Toripalimab in Patients With Advanced Solid Malignancies

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer

Study of AVZO-021 in Patients With Advanced Solid Tumors

Survival Effect of Hepato-celiac Lymphadenectomy In Primary or Relapsed Ovarian Cancer

A Study of PHST001 in Advanced Solid Tumors

A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors

ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors

DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors

A Study of NX-1607 in Adults With Advanced Malignancies

Decitabine and Selinexor in Combination to Reverse Drug Resistance With Standard Chemotherapy in Ovarian Cancer

A Study of DEG6498 in Participants With Solid Tumors

Also recruiting in Europe

Letrozole for Estrogen/Progesterone Receptor positive low-grade serous Epithelial ovarian cancer. A randomized phase III trial. LEPRE Trial

EPITOME-1015-I: A phase I study to investigate the safety and tolerability of MDG1015 in patients with epithelial ovarian cancer, gastroesophageal adenocarcinoma, round cell liposarcoma and/or synovial sarcoma

Epithelial Ovarian Carcinoma trials by city

Other conditions